Camp4 Therapeutics Corp (CAMP) stock
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.00+0.14 (+3.63%)
Close on Nov 17, 2026Market cap $251.01MP/E –Yield 0.00%
Camp4 Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Camp4 Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$28.59M. For fiscal 2025 it was -$29.55M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.55M | – |
| FY2024 | Dec 31, 2024 | -$45.56M | – |
| FY2023 | Dec 31, 2023 | -$44.16M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$12.69M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.98M | – |
| Q4 FY2025 | Dec 31, 2025 | $6.29M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.22M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.34M | – |
| Q1 FY2025 | Mar 31, 2025 | -$14.29M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.29M | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.69M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.44M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.14M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.78M | – |
See a number that looks wrong?